Transglutaminase 2 IgG

If a standard celiac blood test came back negative but your symptoms point toward gluten trouble, the reason might be hidden in how your immune system is built. Some people naturally make very little of one antibody class, and that quirk can make the usual celiac screen falsely reassuring.

This test looks at a different antibody class that keeps working when the standard one is missing. It is the backup signal that catches celiac disease in people the routine panel would otherwise overlook.

What This Antibody Actually Is

Your body makes antibodies, which are proteins the immune system builds to tag specific targets. This test measures IgG (immunoglobulin G) antibodies aimed at TG2 (tissue transglutaminase type 2), an enzyme that stitches and modifies other proteins and sits in many tissues, including the lining of your gut. The test does not measure the enzyme itself. It measures whether your immune system has turned against it.

In celiac disease, this enzyme chemically alters fragments of gluten in a way that makes them look more alarming to the immune system. That reaction sets off both an attack on gluten and, in a telltale sign of the disease, an attack on the enzyme itself. The antibodies this test detects are the fingerprint of that self-attack.

Antibodies come in classes, and the two that matter here are IgA and IgG. Most celiac testing relies on the IgA version because it performs best in the average person. This IgG version becomes valuable mainly when your body cannot make enough IgA to rely on.

Celiac Disease When You Are Low on IgA

Roughly one in forty to fifty people with celiac disease also has selective IgA deficiency, meaning their bodies produce almost no IgA. In these people the standard IgA-based celiac test can read normal even when the disease is active, because there is simply not enough IgA present to detect. That is the gap this IgG test fills. Some guidelines also accept IgG antibodies to deamidated gliadin peptide as an alternative IgG-class test in this situation.

In people with IgA deficiency, this antibody is highly accurate. In a study of 325 IgA-deficient subjects, the IgG anti-TG2 test caught the disease in nearly everyone who had it and correctly cleared nearly everyone who did not (reported sensitivity 98.7% and specificity 98.6%). People carrying celiac-associated genes but no symptoms sometimes tested positive too, which is why a positive result is a signal to investigate, not an automatic diagnosis.

Selective IgA deficiency itself raises celiac risk substantially, on the order of five to sixteen times the general population. If you already know you are IgA deficient, this is the celiac marker that actually works for you.

What High Levels Say About Gut Damage

Higher antibody levels tend to track more severe intestinal injury. When both the IgA and IgG versions of the anti-TG2 antibody are strongly elevated together, they predict more severe flattening of the gut lining (the intestinal damage that defines active celiac disease) with about 99% specificity for the most severe grades. This link between antibody level and gut damage is best established for the IgA version; in one large pediatric study, the IgG level alone did not clearly track mucosal severity in IgA-deficient patients, so read a high IgG number as a reason to investigate rather than a direct gauge of how damaged the lining is.

A positive result can also precede visible damage. In children followed with celiac antibodies but initially normal gut architecture, the projected cumulative incidence of the characteristic intestinal flattening reached 43% by 12 years. A rising or persistent antibody can be an early warning that the disease process is underway before the lining itself gives out.

Signals Reported Outside Celiac Disease

Almost all of the strong evidence for this antibody is about celiac disease. A handful of studies have looked elsewhere, but that work is early and should not drive decisions. In newborns with necrotizing enterocolitis (a serious intestinal illness of premature infants), blood levels of this IgG antibody separated cases from healthy babies reasonably well (caught about 72 out of 100 cases, correctly cleared 95 out of 100) and fell as the infants recovered.

Other findings are mixed or negative. In a large study of adults with unexplained nerve damage or balance problems, this antibody was no more common than in healthy controls. Levels have been reported as elevated months after COVID-19 infection in some people, but what that means clinically is unknown. For an adult ordering this test today, celiac-related autoimmunity is the only interpretation the evidence supports.

Why One Reading Isn't Enough

A single value is a snapshot of one moment. This antibody rises and falls with how much gluten is provoking your immune system, and its interpretation shifts depending on your IgA status and which lab assay was used. Tracking the number over time tells you far more than any one reading, because you can see the direction it is moving.

Trending is especially useful for confirming that things are settling down. In treated celiac disease, these IgG antibodies drop significantly over months once the immune trigger is removed. In people with IgA deficiency, though, the fall is slow: in one series only about 18% had normalized by one year and 36% by two years, so patience and repeated testing matter more than expecting a fast return to normal.

A practical rhythm: establish a baseline, retest in 3 to 6 months if you are changing anything about your gluten intake or gut health, then at least once a year. One caution: this antibody, like the standard IgA version, is an imperfect gauge of whether the gut lining has fully healed. Serology can look normal while damage persists, so a normal number does not always mean the intestine has recovered.

What to Do With an Unexpected Result

A positive or rising result is a starting point for a workup, not a diagnosis on its own. The first companion tests to order alongside it are total IgA (to confirm whether you are truly IgA deficient, which changes how everything is read) and the IgA version of the anti-TG2 antibody. If you are not IgA deficient, an isolated IgG positive result carries much less weight and needs careful interpretation.

When the picture is genuinely suspicious, especially a strongly positive antibody with symptoms like unexplained diarrhea, weight loss, iron deficiency, or a family history of celiac disease, the next step is usually a gastroenterologist, who can confirm the diagnosis with additional serology and, when warranted, a small-intestine biopsy. A confirmatory endomysial antibody test is often used to lock in the result before any lifelong dietary change. Do not start a gluten-free diet before the workup is complete, because doing so can erase the very findings needed to confirm the diagnosis.

When Results Can Be Misleading

Several things can make a single reading unrepresentative. Lead with the biggest one:

• A gluten-free diet at the time of testing: if you have already cut gluten, the immune trigger is gone and antibody levels fall, so the test can miss active disease. Accurate testing requires that you are still eating gluten regularly.
• Which lab and assay were used: commercial kits use different versions of the target enzyme and different cutoffs. Head-to-head testing of anti-TG2 assays found sensitivity ranging from about 76% to 98% across kits, and false-negative rates as high as 24%, so a borderline value from one lab is not directly comparable to another.
• Your IgA status: using this IgG test in someone with normal IgA, rather than in the IgA-deficient group it is designed for, can itself lead to confusion, because it is less sensitive than the standard IgA test in people who make IgA normally.
• Background positivity: in one study, 9.8% of IgA-deficient blood donors without symptoms tested positive, so a positive result does not always equal current disease and needs clinical context.